Power struggle in Shakespeare and his contemporary rewritings
Bu tez size mi ait?
Bu kayıt toplu arşivden geldi. Sizinse profilinize bağlayın.
Özet (EN)
This study focuses on the power struggles in Shakespearean plays, particularly in King Lear and The Tempest. Their rewritings Dunbar by St. Aubyn and Hag-Seed by Atwood share the same plots with different circumstances and settings. Similarly, they contain power struggles seen in contemporary settings. Therefore, to be able to analyse power, and see its effects on the characters, a Foucauldian perspective is going to be practiced. Keeping the fact that Shakespeare plays were written in the 16th and 17th century England in mind, they are going to be studied in terms of their discourse and context initially. Besides, the exercise of power and discipline and its transformation throughout the centuries are going to be exemplified with the help of the four works mentioned above. Key words: King Lear, The Tempest, power, authority, Dunbar, Hag-Seed, discourse, panopticon, surveillance
Yazar
Aylin Sar
Bu Yayına Nasıl Atıf Yapılır
Aylin Sar (Master Thesis). Power struggle in Shakespeare and his contemporary rewritings, 2019, Yeditepe University.
Anahtar Kelimeler
Lisans
Tüm Hakları Saklıdır
Bu eser belirtilen lisans koşulları altında paylaşılmaktadır.
Yeditepe University tezlerinden daha fazlası
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)